Evidence map›Paper›PMID 41141751›Full record

ArticleACS omega2025

Genetically Encoded Cell Fate Reporter System for Multiplex Single-Cell Detection of DNA and Mitochondrial Damage.

Aparna Geetha Jayaprasad, Jain Tiffee Puthanparambil Joseph, Aneesh Chandrasekharan, Aman Munirpasha Halikar, Aswathy Sivasailam, Jithu Thapasimuthu Geetha, Kiran Sasi Kumar, Nithin Satheesan Sinivirgin, Shivanshu Kumar Tiwari, Ashwathi Harikumar and 7 more

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Aparna Geetha JayaprasadCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Jain Tiffee Puthanparambil JosephCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Aneesh ChandrasekharanCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Aman Munirpasha HalikarCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.ORCID https://orcid.org/0000-0002-0163-5644
Aswathy SivasailamCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Jithu Thapasimuthu GeethaCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Kiran Sasi KumarCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Nithin Satheesan SinivirginCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Shivanshu Kumar TiwariCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Ashwathi HarikumarCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Prakash Rajappan PillaiCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Vishnu Sheela SanjeevCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Tilak PrasadCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Surabhi Subramanian VimalaCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Anurup Kochucherukkan GopalakrishnanCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
Shine Varghese JancyCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.
T R SanthoshkumarCancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), Poojappura, Thycaud P.O., Thiruvananthapuram, Kerala 695014, India.ORCID https://orcid.org/0000-0003-3386-7105

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Predicting the mechanism of action of bioactive compounds and toxicants is of great importance in drug discovery, as well as toxicology testing of environmental toxicants. Many reporter cell lines were created for generating phenotypic data in assigning the biological impact of large compound libraries. A major requirement of a phenotypic screen is the reporter cell lines for appropriate biomarkers with a good predictive value. Here, we have developed a stable cell expressing TagBFP2-53BP1 as a real-time sensor for DNA damage at the single-cell level that marks 53BP1 foci formation under physiological conditions, as well as toxicant-induced DNA damage. The cells were further engineered to report mitochondrial permeabilization using Smac-RFP, providing a broader application potential for this cellular model. Once the cells are further expressed with the autophagy marker EGFP-LC3, it is possible to image distinct cell fates such as autophagy, mitochondrial permeabilization, and DNA damage at the single-cell level. Using this system, we demonstrate that early cell death induced by telomerase inhibitors involves double-strand breaks and mitochondrial permeabilization. The model also enabled systematic profiling of several toxicants based on clearly noticeable cell fates. The approach of using live single-cell sensors for multiple distinct and diverse phenotypes offers great advantages over independent single-parameter-based assays, with the additional benefit of extracting heterogeneous cell responses over time, revealing more insight into the toxicity and mechanism of action for predictive applications.

Identifiers

PMID41141751
PMCPMC12547572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.